BioLife Solutions, Inc. (BLFS) News
Filter BLFS News Items
BLFS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest BLFS News From Around the Web
Below are the latest news stories about BIOLIFE SOLUTIONS INC that investors may wish to consider to help them evaluate BLFS as an investment opportunity.
Analysts Just Shaved Their BioLife Solutions, Inc. (NASDAQ:BLFS) Forecasts DramaticallyThe analysts covering BioLife Solutions, Inc. ( NASDAQ:BLFS ) delivered a dose of negativity to shareholders today, by... |
BioLife Solutions (BLFS) was Impacted by Inventory Destocking and Elongated Sales CyclesConestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The micro capitalization segment of the market proved the most challenging in the quarter with the Russell Micro Cap Index declining -7.93%. The Russell Micro Cap Growth Index fell further with a […] |
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call TranscriptBioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst Conference Call. At this time, all participants […] |
BioLife Solutions Reports Third Quarter 2023 Financial ResultsBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the third quarter and nine months of 2023. |
BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter financial results will be released after market close on Thursday, November 9, 2023. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and a general business upda |
Former CEO Michael Rice Sells 72,603 Shares of BioLife Solutions IncOn October 30, 2023, former CEO and Director Michael Rice sold 72,603 shares of BioLife Solutions Inc (NASDAQ:BLFS). |
BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced Roderick de Greef has been appointed as Chairman of the Board of Directors and Chief Executive Officer replacing Michael Rice who is retiring after a seventeen year tenure, effective immediately. Rice has agreed to consult for the Company until March 31, 2024, to support a smooth transition. |
New Strong Sell Stocks for October 9thBLFS, BWMN and FTEK have been added to the Zacks Rank #5 (Strong Sell) List on October 9, 2023. |
Shareholders in BioLife Solutions (NASDAQ:BLFS) are in the red if they invested three years agoInvesting in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of... |
New Strong Sell Stocks for September 13thBLFS, ALCO and AFCG have been added to the Zacks Rank #5 (Strong Sell) List on September 13, 2023. |